Research to Prevent Blindness

RPB researchers honored with 2018 António Champalimaud Vision Award

RPB logo

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More


Groundbreaking Gene Therapy for Retinal Disease

Photo of surgeon and patient

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More


Reversing Retinal Degenerative Diseases: We’re One Step Closer

Dr. Stephen Tsang at work in the lab.

RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.

Read More


Edited Stem Cells Offer Hope for RP Therapy

Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue

Read More


New Gene Therapy for Vision Loss from a Mitochondrial Disease

Gene delivered to mitochondrial DNA

New method for delivering corrective genes to restore energy production in cells could have wide application.

Read More


Renewed Hope for Gene Therapy to Restore Vision

Dr. Tsang

Findings indicate that retinitis pigmentosa is treatable even at advanced disease stages.

Read More


A Passion Fueled By RPB

The Neitzes are internationally recognized for developing a potential gene therapy cure for color blindness and are among the world’s thought leaders on genetic and environmental factors that may be influencing a global epidemic of myopia...

Read More



Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.